Lee Brown, DO
Physical Medicine & Rehabilitation · Clearwater, FLNPI 1982675849
Payments from drug & device makers
Across 20 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$63
- Pacira Therapeutics, Inc.$51
- Novartis$49
- IBSA Pharma Inc.$36
- Pfizer$29
- Boston Scientific$23
- plus $94 from 6 others
What the payments were for
- Food & beverage$345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 4 | $63 |
| Pacira Therapeutics, Inc. | 2 | $51 |
| Novartis | 3 | $49 |
| IBSA Pharma Inc. | 2 | $36 |
| Pfizer | 2 | $29 |
| Boston Scientific | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Osteomed LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$345 in reported general payments places this provider in the 60th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,017 | $23,648 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 330 | $9,654 |
| Gabapentin | 790 | $7,199 |
| Tramadol Hcl | 613 | $6,826 |
| Pregabalin | 310 | $6,331 |
| Morphine Sulfate ErMorphine Sulfate | 108 | $2,133 |
| Celecoxib | 65 | $2,033 |
| Diclofenac Sodium | 128 | $1,438 |
| Baclofen | 141 | $1,352 |
| Cyclobenzaprine Hcl | 148 | $1,192 |
| Tizanidine Hcl | 109 | $1,137 |
| Duloxetine Hcl | 52 | $873 |
| Methocarbamol | 33 | $626 |
| Oxycodone Hcl | 28 | $622 |
| EndocetOxycodone Hcl/Acetaminophen | 21 | $477 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Clearwater
- Michael YuClearwater$47K
- Alan MillerFernandina Beach$784K
- Anthony GiuffridaFort Lauderdale$443K
- Paul WuOakland Park$311K
- Marissa McCarthyTampa$239K
- Ryan HafnerSarasota$200K
- Cassandra ListJacksonville$154K
- Benjamin WesterhausMangonia Park$100K
- Jose Medina SanchezTampa$30K
- Anish SoniNaples$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.